Sorana Segal-Maurer, MD

Sorana Segal-Maurer, MD, offers clinical insights on treating patients with HIV who have viral mutations, including M184V, highlighting guideline recommendations.

An expert on HIV discusses recent real-world studies and research on patient-reported outcomes, detailing treatment algorithms under investigation and their reported tolerability.

Sorana Segal-Maurer, MD, reviews research evaluating the efficacy of B/F/TAF compared with other HIV treatment regimens, including dolutegravir plus tenofovir/FTC.

An infectious disease specialist discusses the differences in binding affinity between dolutegravir and bictegravir and how it informs treatment selection.

Sorana Segal-Maurer, MD, provides an overview of treatment guidelines for the management of patients with HIV and provides insights on currently available therapeutic regimens.

The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.

Experts on HIV offer insights into switching therapies for patients with a history of resistance, highlighting ways to simplify and optimize treatment.

A panel of experts on HIV discuss decision-making practices for patients who have suboptimal response to their current treatment regimen.

Focusing on the management of patients with HIV, the panel provides clinical insights on treatment selection, focusing on long-acting agents.

The panel discusses strategies to predict patients who will have poor adherence to their HIV medications and how to select the best treatment options for them.

Experts on HIV provide clinical insights on testing for drug resistance prior to treatment and approaching the topic of resistance with patients.

Paul E. Sax, MD, and Sorana Segal-Maurer, MD, discuss treatment resistance in HIV and how it has changed over the years.

The panel discusses the importance of starting HIV treatment early after diagnosis and offers advice to clinical providers.

Experts on the treatment of HIV discuss how they talk with their patients about adverse effects associated with HIV regimens.

The panel offers expert perspectives on key factors that inform treatment decisions for patients with HIV.

Focusing on the evolving treatment paradigms for HIV, the panel reviews guideline recommendations for initial therapy and discusses education practices for newly diagnosed patients.

A panel of experts on HIV open the discussion with a conversation about the role of the primary care provider and advanced practice provider in treating patients with HIV.